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Abstract
Background
Detection of drug-resistant tuberculosis is essential for the control of the disease but it is
often hampered by the limitation of transport and storage of samples from remote locations
to the reference laboratory. We performed a retrospective field study to evaluate the perfor-
mance of four supports enabling the transport and storage of samples to be used for molec-
ular detection of drug resistance using the GenoType MTBDRplus.
Methods
Two hundredMycobacterium tuberculosis strains were selected and spotted on slides,
FTA cards, GenoCards, and in ethanol. GenoType MTBDRplus was subsequently per-
formed with the DNA extracted from these supports. Sensitivity and specificity were calcu-
lated and compared to the results obtained by drug susceptibility testing.
Results
For all supports, the overall sensitivity and specificity for detection of resistance to RIF was
between 95% and 100%, and for INH between 95% and 98%.
Conclusion
The four transport and storage supports showed a good sensitivity and specificity for the
detection of resistance to RIF and INH inM. tuberculosis strains using the GenoType
MTBDRplus. These supports can be maintained at room temperature and could represent
an important alternative cost-effective method useful for rapid molecular detection of drug-
resistant TB in low-resource settings.
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Introduction
Tuberculosis (TB), and the emergence of multidrug-resistant (MDR)- and extensively drug-
resistant (XDR)-TB, remains a global health concern, which poses an important challenge for
TB control programs. It is estimated that two billion people are currently infected withMyco-
bacterium tuberculosis (MTB) with 10% of this population at risk of developing the active form
of the disease during their lifetime. According to the last report of the World Health Organiza-
tion (WHO), there were 9.0 million new TB cases in 2013 and 1.5 million TB deaths [1]. TB
control efforts are based on the diagnosis of cases followed by adequate treatment.
Usually, in less-developed settings, cultures are not performed to detect possible drug resis-
tance. Consequently, initial treatment of the disease is performed before the results of drug sus-
ceptibility testing (DST) are available or treatment gets delayed. Yet, rapid detection of drug
resistance is critical for achieving favorable clinical outcomes and preventing the continued
transmission of disease. The obstacles are that DST based on culture takes 3–8 weeks before
obtaining the results, as MTB grows very slowly [2]. DST by culture is a long process and test-
ing also requires a well-equipped biosafety level 3 laboratory, with well-prepared personnel
and dedicated equipment. Moreover, in low-income countries, performing this type of tests is
often restricted by constraints of both sputum storage and safe transport from peripheral
health centers to central laboratories.
Over the last decade, the contribution of molecular methods for the diagnosis of TB has
increased significantly. Molecular assays that can rapidly amplify DNA have been shown to be a
promising alternative especially for developing countries [3]. One of these molecular methods is
the GenoType MTBDRplus (Hain Lifesciences GmBH, Nehren, Germany). The method com-
bines multiplex polymerase chain reaction (PCR) and DNA line-probe assay to identify genetic
mutations conferring rifampicin (RIF) and isoniazid (INH) resistance and can be used on both
cultures and directly on specimens [4]. Microscopy glass slides from routine smear examination
are normally not infectious and susceptible to be transported to other laboratories in other loca-
tions without the need for preservation or costly cold chain. Consequently, they could represent
an ideal material for recovering DNA to be used in downstream molecular tests. Previous studies
have shown their utility for extracting DNA frommycobacteria from several sources [5–9]. Other
systems based on filters such as the FTA card (Whatman International Ltd, UK) and the Geno-
Card (Hain Lifescience, Nehren, Germany) have also been tested to send samples to a reference
laboratory by mail from remote locations [10 – 11]. They could represent a useful tool for collec-
tion and transport of clinical specimens to reference laboratories for a quick detection of drug-
resistant TB. The amplification of the DNA is made by detaching a small disc from the seeded
area of the card, and by directly transferring it to the amplification mix for PCR. To overcome dif-
ficulties of transporting and storing samples using simple ways for downstream DNA-based test-
ing, we performed the first multicenter field evaluation study comparing DNA extracted from
Ziehl-Neelsen (ZN) stained smear slides, from strains spotted on two commercial card-systems:
FTA card and GenoCard, and fromMTB strains kept in ethanol, for the subsequent identification
and genotypic detection of drug-resistant TB using the GenoType MTBDRplus.
Methods
Study sites
This study was conducted at four participating sites: Mycobacteriology Unit, Institute Pasteur
of Madagascar (IPM), Antananarivo, Madagascar; Division of Clinical Microbiology and
Molecular Medicine, All India Institute of Medical Sciences (AIIMS), New Delhi, India;
Mycobacteria Reference Laboratory of Buenos Aires Tuberculosis Control Program Hospital
Molecular Diagnosis MDR-TB
PLOSONE | DOI:10.1371/journal.pone.0139382 October 2, 2015 2 / 11
Dr. Cetrángolo, Buenos Aires, Argentina; Núcleo de Tuberculose e Micobacteriosis, Instituto
Adolfo Lutz, Sao Paulo, Brazil.
Study design
The study was divided in 3 phases. Phase 1 involved 2 parts. In part 1, four non-tuberculous
mycobacteria (NTM) strains (M. chelonae,M. avium,M. abscessus and M. kansasii) were cho-
sen for the standardization of the DNA extraction technique from the 4 different storage and
transport systems: (1) ZN stained smear slides, (2) FTA cards (3) GenoCards, and (4) from eth-
anol. The second part involved the evaluation of six MTB strains from which, three were MDR
and three susceptible, to validate the protocol previously standardized in part 1. In phase 2, the
biosafety related to the viability of the bacilli in the stored samples on the 4 different storage
systems was evaluated using the reference strain MTB H37Rv. Phase 3 was the field evaluation
study at the four participating sites using the GenoType MTBDRplus to detect drug resistance
(RIF and INH) from 50 DNA extracted from the 4 different storage and transport systems. In
this study we use the term of “strains” through all the text which means culture isolates.
Phase 1: Standardization of DNA extraction from different storage and
transport system
Part 1: NTMDNA extraction. Mycobacterial cell suspensions: Four reference NTM
strains:M. chelonae ATCC 14472,M. avium CCUG 27851,M. abscessus CCUG 41449 andM.
kansasii CCUG 32245 were chosen for the standardization of DNA extraction from the differ-
ent storage systems. Bacterial suspensions were prepared by resuspending 1 μl loopful of cells
scraped from Löwenstein-Jensen (LJ) medium in 0.5 ml sterile distilled water. Cell suspensions
were vortexed and adjusted to the scale of McFarland 1 (107–108 CFU/ml). One hundred
microliters of the bacterial suspension was spotted on one microscopy slide, 60 μl on one Gen-
oCard (1 sample area, 1 cm diameter), 100 μl on one FTA card (1 sample area, 125 μl size,
2.5 cm diameter) and 100 μl in 500 μl of absolute ethanol and stored at room temperature until
use. For the GenoCard due to the small area available for spotting the sample, a total volume of
60 μl of bacterial suspension was added by spotting 20 μl in three times, letting dry between
each time. Both filter cards were air dried at room temperature for 15 min in the biosafety cabi-
net before being stored in sealed plastic bags. For the negative control, one drop of sterile dis-
tilled water was spotted in each system.
DNA extraction from ZN stained smear slides: The Chelex method was used according to
Dubois et al. (2011) with small modifications [5]. The oil immersion from the slide was first
removed with Xylene. Twenty five microliter of sterile distilled water was then added to the
slide and the smear scraped off using a sterile scalpel. The suspension was transferred to a 1.5
ml microtube containing 75 μl of 10% Chelex-100. The microtube was then incubated at 95°C
for 30 min then thoroughly mixed and centrifuged at 13000 rpm for 10 min. The supernatant
containing the DNA was transferred to a new microtube and stored at -20°C until further use.
DNA extraction from GenoCard: The DNA extraction from GenoCard was performed
according to Miotto et al. (2008) with small modifications [11]. Briefly, 60 μl of the bacterial
suspension McFarland 1 were spotted directly on the GenoCard sample area as described
above. Using a special punch (Hain Lifescience, Germany), 8 small discs were punched from
the sample spotted area and placed in a microtube. To ensure that there is no cross-contamina-
tion between punched discs from different strains, the cutting end of the punch was rinsed
with 70% ethanol each time. Sixty microliter of 10% Chelex-100 was added in the microtube,
mixed and incubated at 95°C for 30 min. The microtube was then centrifuged at 13000 rpm
for 10 min, and the supernatant transferred to a new microtube and stored at -20°C until use.
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DNA extraction from FTA card: DNA extraction from FTA card was performed according
to Guio et al. (2006) with small modifications [10]. Briefly, 100 μl of the bacterial suspension
McFarland 1 were added on the FTA card sample area as described above. With a Harris
microPunch the card was perforated and discs were transferred to a microtube. 1 disc was ini-
tially punched and tested. The number of discs was then increased to 4 after PCR amplification
result from disc 1. Before each punching, we rinsed the end of the punch (Whatman Interna-
tional Ltd, UK) with 70% alcohol to avoid cross contamination. Discs were rinsed 3 times with
200 μl of Whatman FTA purification reagent (GE Healthcare Life Sciences) to remove PCR
inhibitors and other potential contaminants and to ensure the quality of DNA, and finally
rinsed twice with 200 μl of TE buffer (10 mM TRIS, 1 mM EDTA, pH 8). TE buffer was dis-
carded by pipetting after a short spin at 3000×g and finally 75 μl 10% Chelex-100 was added to
the microtube, mixed and incubated at 95°C for 30 min. After centrifugation at 13000 rpm for
10 min, the supernatant was transferred to a new microtube and stored at -20°C until use.
DNA extraction from strains stored in ethanol: The DNA extraction was performed
according to Montenegro et al. (2003) with minor modifications [12]. Briefly, 100 μl of bacte-
rial suspension Mc Farland 1 was added in a microtube containing 500μl of absolute ethanol.
The suspension was centrifuged at 12000×g for 5 minutes and the supernatant was discarded.
The pellet was washed with 200 μl TE buffer and centrifuged at 12000×g for 10 minutes. The
supernatant was discarded and 75 μl of 10% Chelex-100 was added to the microtube, mixed
and heated at 95°C for 30 minutes. The microtube was then centrifuged at 13000 rpm for 10
minutes and the supernatant was transferred to a new microtube and stored at -20°C until use.
16SrRNA PCR amplification: All DNA extracted from ZN stained smear slide, GenoCard,
FTA card and ethanol systems were first tested with 16SrRNA PCR amplification. PCR product
was checked in 2% agarose gel electrophoresis.
GenoType Mycobacterium CM: The reverse line probe assay GenoTypeMycobacterium
CM was performed according to the manufacturer's instructions, using the reagents provided
with the kits (Hain Lifescience, Nehren, Germany). The GenoType Mycobacterium CM proto-
col consists of PCR amplification, hybridization of the PCR products to the strips, detection of
the hybridization bands, and interpretation of the results. The GenoType Mycobacterium CM
permits the identification of the following mycobacterial species:M. avium,M. chelonae,M.
abscessus,M. fortuitum,M. gordonae,M. intracellulare,M. scrofulaceum,M. interjectum,M.
kansasii,M.malmoense,M.marinum-M. ulcerans,M. peregrinum,M. tuberculosis complex,
andM. xenopi. GenoTypeMycobacterium CM was performed to verify the correct identifica-
tion of the 4 NTM used in the phase 1 from the DNA previously extracted from the 4 systems
of storage.
Part 2: MTB DNA extraction. Six MTB strains (3 MDR and 3 susceptible) were used to
validate the DNA extraction protocol from the 4 storage systems standardized in part 1. The
same DNA extraction protocols were used as described in part 1 for each system. However, the
GenoType MTBDRplus was performed for the detection of MTB with drug resistance to RIF
and INH.
GenoType MTBDRplus: The GenoType MTBDRplus V2 was carried out according to the
manufacturer's instructions (Hain Lifescience, Nehren, Germany). Briefly, for the amplification
process, a total of 5 μl extracted DNA was added to 45μl of PCR mixture containing 10 μl of
amplification Mix A and 35 μl of amplification Mix B provided with the kit. The amplification
protocol consisted of 15 min of denaturing at 95°C, followed by 10 cycles comprising 30s at
95°C and 2min at 65°C, an additional 20 cycles comprising 25s at 95°C, 40s at 50°C, and 40s at
70°C, and a final extension at 70°C for 8 min. Hybridization, detection steps and interpretation
of results were performed according to the manufacturer's instructions.
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Phase 2: Viability testing of MTB on different storage and transport
system
Cell suspensions of 1mg/ml of MTB H37Rv reference susceptible strain (1x107 CFU/ml) and,
10−1 and 10−2 dilutions were added to each transport system and tested for viability by insert-
ing a paper disc of each cell suspension on an LJ medium or by inoculating a ZN-stained mate-
rial scraped off from the microscopic slides on LJ medium and examining for growth for up to
42 days. Growth was quantitated as follows: “1+” if the number of colonies is between 50–100;
“2+” if it’s between 100–200 colonies and “3+” if it’s more than 200 colonies or confluent
colonies.
In a first experiment, to test the viability of bacteria spotted on slide, 100 μl of MTB H37Rv
suspension (1 mg/ml) were spread on 2 slides and fixed by heating. After fixation, one of the
slides was stained by ZN, and then the smear scraped off the slide using 25 μl of distilled water.
The suspension was transferred to a microtube and decontaminated with sodium dodecyl (lau-
ryl) sulphate-NaOH (SDS–NaOH), inoculated on LJ medium and incubated at 37°C for up to
42 days for colony counting. For the other slide, after fixation, the smear was directly removed
without prior ZN staining, decontaminated, inoculated on LJ medium and incubated at 37°C
for up to 42 days. For the FTA and GenoCard, 100 μl and 60 μl of MTB H37Rv suspension
(1 mg/ml) were inoculated on each card, respectively, and left them dry at room temperature
inside the biosafety cabinet. Viability testing was determined after different contact times with
bacterial cells: directly after drying corresponding to time 0 (T0), after 15 min (T15), 30 min
(T30), 1h (T1h) and 1 night (T 1 night). At each time point, 3 discs were punched, placed into
500 μl sterilized distilled water and mixed. The suspension was inoculated on LJ and incubated
at 37°C for up to 42 days. The viability testing in ethanol was tested by inoculating 100 μl of
MTB H37Rv suspension (1 mg/ml) in 500 μl of absolute ethanol. Directly at T0, 100 μl of the
suspension was inoculated on LJ and incubated at 37°C for up to 42 days.
In a second experiment, according to the results observed in the first experiment and in
order to ensure the safety of the GenoCard and FTA cards, the viability of the mycobacterial
cells was tested by spotting a suspension of MTB H37Rv (1 mg/ml, 10−1 and 10−2) on Geno-
Card and FTA cards and inactivated by using different concentrations of ethanol. The same
protocol as described in the first experiment was followed. After spotting the suspension at dif-
ferent dilutions, and after drying them, 100 μl of 70% ethanol was added to one card, 100 μl of
90% ethanol to a second card, 100 μl of absolute ethanol to a third card and the last card with-
out ethanol was used as a control. For each test (GenoCard and FTA cards), after 1 hour and
after 1 night of contact, 3 discs were punched and added to a microtube containing 500 μl dis-
tilled water and directly inoculated on LJ and incubated at 37°C for up to 42 days. Each experi-
ment was performed twice.
Phase 3: Field evaluation of the four different storage and supports
Each participating site selected 50 MTB clinical strains (25 MDR-TB and 25 susceptible). To
confirm their resistance profile, they were subcultured on LJ medium for testing susceptibility
to RIF and INH by the proportion method on LJ or in the MGIT960 system. The McFarland
1 suspension of MTB strains were spotted on the different storage supports to validate the
DNA extraction protocol for the detection of MDR-TB using the GenoType MTBDRplus as
described in phase I. All tests were performed blindly without knowing the resistance profile of
the strains tested and results were compared to those obtained by the conventional DST
method. Before starting, to ensure that the same study procedure was followed, the laboratory
of microbiology from the University of Ghent prepared the standard operating protocol and
distributed it to each site.
Molecular Diagnosis MDR-TB
PLOSONE | DOI:10.1371/journal.pone.0139382 October 2, 2015 5 / 11
Data analysis
The performance of the DNA extraction method from each storage support to detect RIF and
INH resistance was assessed separately by calculating sensitivity and specificity with standard
methods. Sensitivity was defined as the ability to detect true resistance, and specificity was
defined as the ability to detect true susceptibility. For the mycobacterial viability testing,
the standard deviation (± SD) was calculated using excel (average colonies numbers of
2 experiments).
Results
Phase 1: Standardization of DNA extraction from each storage and
transport system
Part 1. We first standardized and optimized the DNA extraction protocol from the differ-
ent storage supports using NTM. For the DNA extraction from suspensions spotted on FTA
cards, we initially found that 1 punched disc was not enough for PCR amplification. The
16SrRNA amplification product was negative in 2% agarose gel electrophoresis. However,
DNA extraction from 4 discs by using the 10% Chelex-100 method showed a very good and an
optimal PCR result (Fig 1). Similarly, DNA extraction from the mycobacterial cells spotted on
GenoCard was standardized with 8 punched discs by using the 10% Chelex-100 method
(Fig 1). Equally satisfactory results with or without 10% Chelex-100 were obtained for both
cards. Nevertheless, the DNA extraction protocol using 10% Chelex-100 was selected for the
field evaluation because it has the advantage of allowing having a sufficient amount of DNA
(75μl) for subsequent additional tests, which is not possible using directly the punched discs in
the PCR mix. The Chelex DNA extraction methods from ZN smear and from the strain kept in
ethanol gave also satisfactory results (Fig 1). All NTM were correctly identified by GenoType
Mycobacterium CM using the 4 storage and transport systems.
Part 2. Also, the six MTB strains were correctly identified as susceptible or resistant by the
GenoType MTBDRplus from DNA extracted in the four systems of storage using also Chelex
method.
Phase 2: Viability testing of MTB on different storage and transport
system
For the viability testing, LJ was inoculated from the different supports spotted with MTB
H37Rv and results are presented in Table 1. After 42 days, no growth was observed on LJ slants
which were inoculated from ZN stained smears and from the suspension kept in ethanol. How-
ever, visible growth on LJ was observed (1+ or 2+) from discs seeded with MTB H37Rv from
the FTA card and GenoCard at the different contact times. In the second experiment, the aver-
age growth from FTA card and GenoCard after the addition of 70%, 90% and absolute ethanol
is presented in Table 1. Visible growth was still observed in 70% ethanol at the two contact
points and viability was not lost even at the lower bacterial concentration (10−2). Interestingly,
no growth was observed using 90% ethanol or absolute ethanol.
Phase 3: Field evaluation of four different storage and supports
Results of the field evaluation are shown in Table 2. In total 200 strains were processed on
four different supports at the four sites. From strains spotted on slides, a total of 195 were cor-
rectly identified by the GenoType MTBDRplus. DNA extraction was negative from one sample
(site 2). The GenoType MTBDRplus assay was considered as invalid (no TUB signal) from 4
samples (site 3). For the GenoCard system, a total of 194 samples were correctly identified by
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GenoType MTBDRplus. Three samples gave invalid results (site 3) (no signal TUB) and the
DNA extraction was negative from another three samples (site 2). For the FTA card all 200
strains were correctly identified by GenoType MTBDRplus. For strains stored in ethanol, 197
were correctly identified. DNA extraction was negative from 2 samples (site 2), and one invalid
result was obtained by Genotype MTBDRplus (site 3). Table 3 shows the specificity and sensi-
tivity obtained for each system. For both drugs an excellent agreement was obtained between
the GenoType MTBDRplus and the reference DST method performed at each site. Three sites
reported 100% sensitivity and 100% specificity. Site 4 obtained a sensitivity between 80% and
84% for both drugs and specificity between 88% and 100% for all supports. The overall sensitiv-
ity and specificity for all sites was of 95 to 100%.
Discussion
To our knowledge, this is the first multicenter field study that explores the use of four transport
and storage systems simultaneously, demonstrating the feasibility of using DNA extracted
from different supports forM. tuberculosis resistance testing with the GenoType MTBDRplus
assay. We have to point out that the major limitation of this study is the use ofM. tuberculosis
strains and not of sputum samples. This was the purpose of this work, to demonstrate for the
first time in a multicenter study evaluation the comparative performance of several transports
systems before applying them to sputum samples. We have also addressed for the first time the
Fig 1. 16SrRNA PCR results on 2% agarose gel. The appearance of 921 bp PCR amplicon indicates the positive results for MTB. M: marker, lane 1: from
ethanol; lane 2: from FTA card; lane 4; from GenoCard; lane 4: from slide.
doi:10.1371/journal.pone.0139382.g001
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safety issue of using these systems and set-up the best DNA extraction method to be used in
the prospective field evaluation using sputum samples (ongoing study). Our study demon-
strated that DNA extracted from these supports can be amplified successfully using the Chelex
method and drug resistance correctly detected by the molecular test. Overall, high sensitivities
and specificities in detecting RIF (96% to 100%) and INH (94% to 98%) resistance were
obtained from DNA extracted from each storage system compared with the conventional DST
method. Very few studies have evaluated these supports of storage and transport for molecular
detection of drug resistance. Guio et al., (2006) amplified MTB IS6110 region from sputum
samples spotted on FTA cards and compared with the results of microscopy examination and
found that the sensitivity and specificity of PCR using the FTA card system were higher than
microscopy examination. Tortoli et al. (2008) evaluated the performance of the GenoCard
using MTB strains and showed that all samples produced good quality amplification products
and good 16SrDNA sequencing results [13]. Also, Miotto et al. (2008) evaluated the perfor-
mance of the GenoCard for the identification of MDR-TB using the GenoType MTBDRplus
and for molecular typing by Mycobacterial Interspersed Repetitive Units Variable Number
Tandem Repeats (MIRU-VNTR) and found it a useful tool for transport and storage of sam-
ples for quick monitoring of drug-resistance [11]. In our study, few discordant results were
found compared to the conventional method. Some strains were found resistant with the pro-
portion method but susceptible by GenoType MTBDRplus and the opposite was also shown
for a few strains. One possible explanation might be that phenotypic resistance was due to
other gene mutations not incorporated into the strip of GenoType MTBDRplus [14–16]. We
believe that the discordances could be attributed to the proportion method and not to the qual-
ity of the DNA extracted, since the results of the GenoType MTBDRplus from all supports
were concordant. However, this study could be an innovative approach for the rapid detection
of MDR-TB taking only 2 days for results. Moreover, resistance to second-line drugs such as
Table 1. Mycobacterial viability testing.
1st experiment: H37Rv
Supports
Slide Ethanol FTA card GenoCard
No ZN ZN T0 T0 T15 T30 T1h T1 night T0 T15 T30 T1h T1 night
N° colonies on LJ 0 0 0 2+ 1+ 1+ 1+ 1+ 2+ Cont. 2+ 2+ 2+
2nd experiment: H37Rv + Ethanol
Supports
FTA card GenoCard
N° colonies on LJ T1h [± SD] T1 night [± SD] T1h [± SD] T1 night [± SD]
Ethanol 70% 1 mg/ml 2+ 34 ± 7.1 2+ 71 ± 1.4
10−1 1+ 1+ 30 ± 1.4 5 ± 0.7
10−2 39 ± 4.2 3 ± 1.4 8 ± 7.1 0
Ethanol 90% 1 mg/ml 0 0 0 0
10−1 0 0 0 0
10−2 0 0 0 0
Absolute
ethanol
1 mg/ml 0 0 0 0
10−1 0 0 0 0
10−2 0 0 0 0
No ZN = no ZN staining, Cont. = contaminated, T0: time zero, T15: 15 min contact, T30: 30 min contact, T1h: 1 h contact, T1 night: 1 night contact.
SD = Standard Deviation.
doi:10.1371/journal.pone.0139382.t001
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fluoroquinolones and injectable drugs using the Genotype MTBDRsl should also be possible. It
is important to point out that the bacilli may remain viable and confer an infection risk after
spotting the cells on filter paper [17]. Transportation of MTB strains needs to be safe. Our data
Table 2. Susceptibility results of 50M. tuberculosis strains obtained by Genotype MTBDRplus performed on the DNA extracted from different sup-
ports in each site compared to the LJ /MGIT960.
Genotype MTBDRRplus
Slide GenoCard FTA card Ethanol
Study sites Drugs LJ/MGIT960 R S R S R S R S
Site 1 RIF R 25 0 25 0 25 0 25 0
S 0 25 0 25 0 25 0 25
INH R 25 0 25 0 25 0 25 0
S 0 25 0 25 0 25 0 25
Site 2 RIF R 24 0 23 0 25 0 24 0
S 0 25 0 24 0 25 0 24
INH R 24 0 23 0 25 0 24 0
S 0 25 0 24 0 25 0 24
Site 3 RIF R 22 0 22 0 25 0 25 0
S 0 24 0 25 0 25 0 24
INH R 23 0 23 0 26 0 26 0
S 0 23 0 24 0 24 0 23
Site 4 RIF R 21 4 20 5 21 4 21 4
S 0 25 0 25 0 25 1 24
INH R 20 5 20 5 21 4 20 5
S 2 23 2 23 2 23 3 22
R = resistant, S = susceptible, RIF = Rifampicin, INH = Isoniazid
Site 2: slide n = 49 (1 sample excluded: DNA extraction negative); GenoCard n = 47 (3 samples excluded: DNA extraction negative); Ethanol n = 48 (2
samples excluded: DNA extraction negative)
Site 3: slide n = 46 (4 samples invalid: no signal TUB); Genocard n = 47 (3 samples invalid: no signal TUB); Ethanol n = 49 (1 invalid result).
doi:10.1371/journal.pone.0139382.t002
Table 3. Specificity and sensitivity of the GenotypeMTBDRplus performed on the DNA extracted from different support in each site compared to
conventional method.
Slide GenoCard FTA card Ethanol
Study sites Drugs Sens (%) Spec (%) Sens (%) Spec (%) Sens (%) Spec (%) Sens (%) Spec (%)
Site 1 RIF 100 100 100 100 100 100 100 100
INH 100 100 100 100 100 100 100 100
Site 2 RIF 100 100 100 100 100 100 100 100
INH 100 100 100 100 100 100 100 100
Site 3 RIF 100 100 100 100 100 100 100 100
INH 100 100 100 100 100 100 100 100
Site 4 RIF 84 100 80 100 84 100 84 96
INH 80 92 80 92 84 92 80 88
All sites RIF 96 100 95 100 96 100 96 99
INH 95 98 95 98 96 98 95 97
Sens = sensitivity, Spec = speciﬁcity, RIF = Rifampicin, INH = Isoniazid
doi:10.1371/journal.pone.0139382.t003
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clearly showed that FTA and GenoCard did not inactivate MTB H37Rv strain. Even the FTA
lysis buffer was shown to be not sufficiently effective in inactivating mycobacterial cells. Rajen-
dram et al. (2006) also reported that the viability of cells retained on the FTA cards varied
among broad groups of bacteria. For Gram negative species, no viable cells were retained even
at high cell densities and for the most robust species such as spore-formers and acid-fast bacte-
ria, complete inactivation was achieved only at low cell densities [18]. In our study, using 90%
or absolute ethanol rendered bacteria seeded on filter paper cards completely non-viable.
Therefore to ensure the safe handling of the GenoCard and FTA card, inactivation of infectious
bacteria spotted onto the cards must be ensured by simply adding a drop of 90% ethanol or
absolute ethanol. Without this treatment, FTA cards and GenoCard spotted with samples con-
taining live MTB should be considered as potentially infectious and should be handled care-
fully. However, using smear microscopy, after staining the smears, no mycobacteria will
remain viable and the smears become safe for handling, as reported earlier, which is in concor-
dance with our results [19].
Conclusion
Due to the simplicity and ease of transport, these support systems could represent an important
economical and cost-effective alternative for subsequent molecular detection of drug resistance
in TB. They have the potential for a widespread use in remote endemic areas where specimens
have to be transported through long distances to the laboratory. They can be stored at room
temperature until needed for molecular analysis; however, more work is needed to assess the
DNA stability on these supports for a long period of time. The optimal DNA extraction
method was explored and we recommend using 10% Chelex-100, which gave very good PCR
and molecular results. Care must be taken to avoid cross-contamination when punching the
discs between the cards. GenoCard has the advantage that no purification step is needed, the
punched disc can be used directly for PCR. Besides, another great advantage is that the cards
are easy to label and handle. Evaluation of the potential use of these four systems to detect RIF
and INH resistance from direct sputum samples is under evaluation.
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